Long before Moderna and Pfizer’s COVID-19 shots, scientists had been considering the use of genetically encoded vaccines in the fight against infectious diseases, cancer, and more.
The so-called 614G mutation in the viral spike protein does not appear to cause more severe cases of COVID-19, but multiple studies indicate that it could be more contagious.
Weill Cornell Medicine geneticist Christopher Mason speaks with The Scientist about a bolus of new work on the physiological, cellular, and molecular effects of leaving Earth.
Thomas Stoeger of Northwestern University has previously studied scientists’ limited focus on certain genes. In a new study, he shows how these same behaviors extend into the science of COVID-19.
A study makes policy recommendations to optimize citations, but critics say it fails to acknowledge that citations are a biased and narrow measure of scientific success.
Responses collected from around 25,000 academics reveal that 20 percent couldn’t do their work at all in the spring, but most had found ways to keep their research going.
Academics will soon be able to make articles freely available in Nature-branded journals for €9,500—with a discounted option available under a pilot program that provides review, but no guarantee of acceptance.
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
The variant causes a buildup of BACE1 protein in axons in cultured neurons and mice. Researchers say it might be time to rethink failed trials that inhibit BACE1 to treat the neurodegenerative disease.
